Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SYBX

Synlogic Inc

Nov 28 • 04:00PM ET

2.09

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.72	Insider Own	50.61%	Shs Outstand	9.19M	Perf Week	0.48%
Market Cap	19.21M	Forward P/E	-	EPS next Y	-5.09	Insider Trans	0.00%	Shs Float	4.54M	Perf Month	12.37%
Income	-59.44M	PEG	-	EPS next Q	-0.93	Inst Own	19.20%	Short Float / Ratio	2.00% / 2.40	Perf Quarter	-72.26%
Sales	0.71M	P/S	27.05	EPS this Y	62.66%	Inst Trans	-15.05%	Short Interest	0.09M	Perf Half Y	-75.55%
Book/sh	9.44	P/B	0.22	EPS next Y	1.16%	ROA	-61.13%	Target Price	29.50	Perf Year	-77.30%
Cash/sh	3.64	P/C	0.57	EPS next 5Y	-	ROE	-82.66%	52W Range	1.61 - 16.50	Perf YTD	-81.67%
Dividend	-	P/FCF	-	EPS past 5Y	31.24%	ROI	-104.09%	52W High	-87.33%	Beta	1.07
Dividend %	-	Quick Ratio	4.13	Sales past 5Y	21.00%	Gross Margin	-668.22%	52W Low	29.81%	ATR	0.28
Employees	72	Current Ratio	4.13	Sales Q/Q	-42.04%	Oper. Margin	-8732.06%	RSI (14)	45.83	Volatility	10.94% 13.30%
Optionable	No	Debt/Eq	0.42	EPS Q/Q	31.03%	Profit Margin	-8396.05%	Rel Volume	0.00	Prev Close	2.09
Shortable	Yes	LT Debt/Eq	0.32	Earnings	Nov 09 BMO	Payout	-	Avg Volume	37.76K	Price	2.09
Recom	1.00	SMA20	5.41%	SMA50	-18.83%	SMA200	-69.85%	Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-24-21	Upgrade	Oppenheimer	Perform → Outperform	$7
Aug-21-19	Downgrade	Oppenheimer	Outperform → Perform
Apr-30-19	Initiated	Jefferies	Buy	$18
Dec-13-18	Initiated	Chardan Capital Markets	Buy	$20
Mar-19-18	Initiated	H.C. Wainwright	Buy	$20
Jan-29-18	Initiated	Piper Jaffray	Overweight	$16

Nov-14-23 08:55AM	Sidoti Events, LLCs Virtual November Micro-Cap Conference (ACCESSWIRE) +17.78%
Nov-09-23 07:19AM	Synlogic Inc (SYBX) Reports Q3 2023 Financial Results with Extended Cash Runway and Clinical ... (GuruFocus.com) -15.02%
07:00AM	Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-07-23 07:00AM	Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration (GlobeNewswire)
Nov-02-23 10:00AM	Synlogic, Inc. (SYBX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
04:15PM	Loading…
Oct-03-23 04:15PM	Synlogic Announces Closing of $21.0 Million Underwritten Public Offering (GlobeNewswire) -7.72%
Sep-29-23 07:00AM	Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering (GlobeNewswire) -11.08%
Sep-28-23 11:15AM	Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism (GlobeNewswire) -24.49%
09:13AM	Why Is Synlogic (SYBX) Stock Down 6% Today? (InvestorPlace)
Sep-27-23 12:30PM	Synlogic Announces Reverse Stock Split (GlobeNewswire) -15.48%
Sep-21-23 07:00AM	Synlogic to Participate in Chardans Genetic Medicines Conference (GlobeNewswire)
Sep-19-23 11:00AM	Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100 (GlobeNewswire) -21.79%
Aug-10-23 08:40AM	Synlogic, Inc. (SYBX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-11-23 07:00AM	Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria (GlobeNewswire) +5.49%
07:00AM	Loading…
Jun-28-23 07:00AM	Synlogic Announces International Nonproprietary Name Selection for SYNB1934 (GlobeNewswire) -9.78%
Jun-27-23 07:00AM	Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum (GlobeNewswire) +15.68%
Jun-08-23 06:45AM	Synlogic Reminds Stockholders of 2023 Annual General Meeting Details (GlobeNewswire)
Jun-05-23 06:45AM	Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria (GlobeNewswire) -14.65%
May-24-23 06:35AM	Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference (GlobeNewswire)
May-23-23 06:50AM	Synlogic to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-13-23 08:21AM	Synlogic First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-11-23 12:38PM	3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year (InvestorPlace)
08:05AM	Synlogic, Inc. (SYBX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
06:50AM	Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE) -10.36%
06:50AM	Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria (GlobeNewswire)
May-04-23 10:00AM	Analysts Estimate Synlogic, Inc. (SYBX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-28-23 05:12PM	3 Megatrend Stocks to Buy for 10x Potential Returns (InvestorPlace)
Mar-29-23 07:55AM	Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
06:40AM	Loading…
06:40AM	Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates (GlobeNewswire)
Mar-28-23 06:52AM	Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria (GlobeNewswire) +5.32%
Mar-20-23 06:55AM	Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting (GlobeNewswire) +7.81%
Mar-10-23 08:35AM	Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing (GlobeNewswire) -10.37%
Mar-08-23 07:00AM	Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference (GlobeNewswire)
Mar-07-23 08:35AM	Life Sciences Virtual Investor Forum Agenda Announced for March 9th (GlobeNewswire)
06:57AM	Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting (GlobeNewswire)
Jan-24-23 06:57AM	Synlogic Announces Participation in Upcoming Investor and Industry Conferences (GlobeNewswire)
Jan-19-23 06:58AM	Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU) (GlobeNewswire)
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference (ACCESSWIRE)
Jan-16-23 12:00PM	Synlogic, Inc. (SYBX) Upgraded to Buy: Here's Why (Zacks)
Jan-14-23 07:17AM	Even after rising 15% this past week, Synlogic (NASDAQ:SYBX) shareholders are still down 90% over the past five years (Simply Wall St.)
Jan-05-23 06:58AM	Synlogic Provides Corporate Update and Outlook for 2023 (GlobeNewswire) +11.33%
Jan-03-23 06:58AM	Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and Development (GlobeNewswire)
Dec-15-22 10:49AM	Synlogic's Experimental Drug Lowers Urinary Oxalate In Gastric Bypass Patients (Benzinga) +8.28%
06:59AM	Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study (GlobeNewswire)
Dec-04-22 09:27AM	Will Synlogic (NASDAQ:SYBX) Spend Its Cash Wisely? (Simply Wall St.)
Nov-30-22 04:15PM	Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update (GlobeNewswire)
Nov-10-22 08:05AM	Synlogic, Inc. (SYBX) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.88%
06:59AM	Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-18-22 11:15AM	Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year (Benzinga)
06:59AM	Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3 (GlobeNewswire)
Sep-06-22 07:00AM	Synlogic Achieves Research Milestone in Collaboration with Roche for Development of Novel Synthetic Biotic to Treat Inflammatory Bowel Disease (GlobeNewswire)
Aug-23-22 07:00AM	Synlogic Granted FDA Fast Track Designation for SYNB1353 for the Treatment of Homocystinuria (HCU) (GlobeNewswire)
Aug-11-22 03:50PM	Ginkgo Bioworks partners with Synlogic on new gout drug (Yahoo Finance Video) +11.22%
08:15AM	Synlogic, Inc. (SYBX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:05AM	Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks (PR Newswire)
06:58AM	Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Jul-28-22 07:00AM	Synlogic Announces Second Quarter 2022 Conference Call and Webcast (GlobeNewswire) -7.58%
Jul-12-22 07:00AM	Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria (HCU) (GlobeNewswire)
Jun-29-22 07:00AM	Synlogic Announces Appointment of General Counsel and Corporate Secretary (GlobeNewswire)
Jun-28-22 07:00AM	Synlogic to Present at the 2022 National PKU Alliance (NPKUA) Conference (GlobeNewswire) -6.19%
Jun-27-22 10:06AM	Is Synlogic (NASDAQ:SYBX) In A Good Position To Invest In Growth? (Simply Wall St.)
Jun-21-22 07:00AM	Synlogic to Present at the 2022 HCU Network America, Organic Acidemia Association and Propionic Acidemia Foundation Conference (GlobeNewswire) +9.62%
Jun-01-22 07:00AM	Synlogic Reminds Stockholders of 2022 Annual General Meeting Details (GlobeNewswire)
May-24-22 07:00AM	Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1618 for the Treatment of Phenylketonuria (GlobeNewswire) -7.44%
May-12-22 10:51AM	Synlogic (NASDAQ:SYBX shareholders incur further losses as stock declines 28% this week, taking three-year losses to 85% (Simply Wall St.) -14.40%
08:35AM	Synlogic, Inc. (SYBX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Synlogic Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-05-22 07:00AM	Synlogic Announces First Quarter 2022 Conference Call and Webcast (GlobeNewswire) -6.36%
Apr-28-22 07:00AM	Synlogic Announces Data Presentations at the 2022 Genetic Metabolic Dieticians International (GMDI) Conference and Garrod Symposium (GlobeNewswire)
Apr-26-22 07:00AM	Synlogic Announces Data Presentations from Five Programs at the 2022 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference (GlobeNewswire)
Apr-01-22 07:00AM	Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting (GlobeNewswire)
Mar-17-22 08:25AM	Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-10-22 07:00AM	Synlogic Announces Fourth Quarter and Full Year 2021 Conference Call and Webcast (GlobeNewswire)
Mar-03-22 07:00AM	Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer (GlobeNewswire)
Feb-24-22 07:00AM	Synlogic To Present at Upcoming Investor and Industry Conferences (GlobeNewswire)
Feb-08-22 07:00AM	Synlogic To Present at Upcoming Investor and Industry Conferences (GlobeNewswire)
Jan-11-22 08:59AM	Will Synlogic (NASDAQ:SYBX) Spend Its Cash Wisely? (Simply Wall St.)
Jan-06-22 07:00AM	Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences (GlobeNewswire)
Dec-24-21 12:00PM	What Makes Synlogic, Inc. (SYBX) a New Buy Stock (Zacks)
Nov-30-21 10:54AM	These 2 Penny Stocks Are Set for Massive Gains, Says Oppenheimer (TipRanks)
Nov-22-21 07:45PM	Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 (PR Newswire) -6.08%
Nov-18-21 01:04PM	AbbVie's (ABBV) Skyrizi Gets Nod for Psoriatic Arthritis in EU (Zacks) -6.34%
12:58PM	Novavax (NVAX) COVID Jab Gets Philippines Nod, Under Review in EU (Zacks)
Nov-17-21 10:45AM	CRISPR (CRSP) to Begin Clinical Study on Diabetes Therapy Drug (Zacks)
Nov-12-21 11:29AM	Synlogic (NASDAQ:SYBX) shareholders have endured a 69% loss from investing in the stock three years ago (Simply Wall St.)
Nov-10-21 08:35AM	Synlogic, Inc. (SYBX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Synlogic Reports Third Quarter Financial Results and Provides Business Update (PR Newswire)
07:00AM	Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting (PR Newswire)
Nov-09-21 07:00AM	Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria (PR Newswire)
Nov-02-21 08:00AM	Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference (PR Newswire)
Oct-28-21 07:00AM	Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria (PR Newswire)
Oct-15-21 10:30AM	Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021 (PR Newswire)
Oct-12-21 04:05PM	Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform (PR Newswire)
Oct-01-21 07:45PM	Dice Therapeutics and Hemisphere Media Stock See Action From Activist Investors (Barrons.com)
Sep-27-21 11:55AM	10 Cheap Pharmaceutical Stocks to Watch (Insider Monkey)
06:30AM	Synlogic Appoints Molly Harper as Chief Business Officer (PR Newswire)
Sep-22-21 11:32PM	Synlogic Announces Pricing of Public Offering of Common Stock (PR Newswire)

Synlogic, Inc. engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on August 28, 2017, and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brennan Aoife	See Remarks	Apr 03	Sale	0.58	19,042	10,964	256,301	Apr 05 04:15 PM
Awad Antoine	Chief Operating Officer	Apr 03	Sale	0.58	6,438	3,707	74,732	Apr 05 04:15 PM
JENSEN MICHAEL VANGSTED	Chief Financial Officer	Apr 03	Sale	0.58	2,553	1,470	46,947	Apr 05 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SYBX

Synlogic Inc

Upgrade your FINVIZ experience